{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:08:27Z","timestamp":1788761307250,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurological deficits after spontaneous intracerebral hemorrhage (ICH) are linked to treatment discontinuation in acute leukemia patients, but underlying mechanisms are unknown. We tested whether cognitive impairment mediates this relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center retrospective cohort study (2016\u20132024), we included 102 acute leukemia patients who survived \u22656 months post-ICH and remained on hematologic treatment at the 6 month landmark. Neurological deficit at discharge [modified Rankin Scale (mRS), 0\u20132 vs. 3\u20135] was the exposure; MoCA score at 6 months was the mediator; time to permanent treatment discontinuation (non progression) was the outcome. We applied counterfactual mediation analysis with 1,000 bootstraps, reporting natural direct\/indirect effects (NDE\/NIE) as hazard ratios (HRs). We tested the proportional hazards assumption, quantified inter-rater agreement for outcome adjudication, and performed sensitivity analyses (continuous exposure, binary mediator, competing risks, and E-value).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean MoCA was 22.0 (SD 5.2); 48.0% had impairment (MoCA\u2009&amp;lt;\u200926). Over 12 month median follow up, 44.1% discontinued. Total effect of mRS 3\u20135 (vs. 0\u20132) was HR 3.42 (95% CI 2.05\u20135.72). Decomposition yielded NDE 2.08 (1.13\u20133.84) and NIE 1.64 (1.17\u20132.32), with 42.1% (15.4%\u201368.4%) mediated via cognition. Sensitivity analyses produced consistent estimates (NIE range 1.25\u20131.55; mediated proportion 35.8%\u201338.9%); E-value for NIE was 2.66 (lower CI 1.62).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this cohort of 6-month ICH survivors with acute leukemia, cognitive impairment was estimated to mediate 42.1% of the neurological deficit effect on hematologic treatment discontinuation. These findings are hypothesis-generating and suggest that post-ICH cognitive dysfunction may be a modifiable mechanism. Cognitive screening and early rehabilitation may warrant integration into post-ICH care; prospective trials are needed to test whether cognitive interventions improve treatment persistence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1928027","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T05:36:01Z","timestamp":1788759361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cognitive impairment as a mediator of treatment discontinuation after intracerebral hemorrhage in acute leukemia"],"prefix":"10.3389","volume":"13","author":[{"given":"Wentao","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Neurosurgery, Ganzhou People's Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Neurosurgery, Ganzhou People's Hospital","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Hematology, Ganzhou People's Hospital","place":["Ganzhou, China"]},{"name":"Jiangxi Health Commission Key Laboratory of Leukemia, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Hematology, Ganzhou People's Hospital","place":["Ganzhou, China"]},{"name":"Jiangxi Health Commission Key Laboratory of Leukemia, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University","place":["Ganzhou, China"]},{"name":"Department of Hematology, Ganzhou People's Hospital","place":["Ganzhou, China"]},{"name":"Jiangxi Health Commission Key Laboratory of Leukemia, the Affiliated Ganzhou Hospital, Jiangxi Medical College, Nanchang University","place":["Ganzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1597070","DOI":"10.3389\/fmed.2025.1597070","article-title":"Exploration of neuroprotective strategies in patients with acute promyelocytic leukemia complicated by cerebral hemorrhage","volume":"12","author":"Hu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"103433","DOI":"10.1016\/j.rpth.2026.103433","article-title":"Cathepsin G is associated with cerebral vascular injury in myeloid leukemia: a pathologic insight into intracranial hemorrhage","volume":"10","author":"Gi","year":"2026","journal-title":"Res Pract Thromb Haemost"},{"key":"B3","doi-asserted-by":"publisher","first-page":"111543","DOI":"10.1016\/j.ejrad.2024.111543","article-title":"Machine learning-based model for predicting outcomes in cerebral hemorrhage patients with leukemia","volume":"177","author":"Shi","year":"2024","journal-title":"Eur J Radiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1016\/S2352-3026(23)00073-X","article-title":"Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial","volume":"10","author":"Jabbour","year":"2023","journal-title":"Lancet Haematol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4103\/ijc.IJC_422_19","article-title":"Acute neurological complications during acute lymphoblastic leukemia therapy: a single-center experience over 10 years","volume":"58","author":"Rahiman","year":"2021","journal-title":"Indian J Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.122.319951","article-title":"Post-stroke cognitive impairment and dementia","volume":"130","author":"Rost","year":"2022","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.wneu.2021.01.026","article-title":"Cognitive impairment after intracerebral hemorrhage: a systematic review and meta-analysis","volume":"148","author":"Kazim","year":"2021","journal-title":"World Neurosurg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"667511","DOI":"10.3389\/fneur.2021.667511","article-title":"Behavioral assessment of sensory, motor, emotion, and cognition in rodent models of intracerebral hemorrhage","volume":"12","author":"Shi","year":"2021","journal-title":"Front Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/acn3.51957","article-title":"Impact of early cognitive impairment on outcome trajectory in patients with intracerebral hemorrhage","volume":"11","author":"Li","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"ii54","DOI":"10.1093\/ndt\/gfae249","article-title":"Chemotherapy-related cognitive impairment and kidney dysfunction","volume":"40","author":"Simeoni","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/13803395.2025.2539199","article-title":"Neurotoxicity of chemotherapy and brain-radiotherapy in cancer: overlapping mechanisms underlying cognitive impairment","volume":"47","author":"Kuil","year":"2025","journal-title":"J Clin Exp Neuropsychol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s00277-022-04982-w","article-title":"Clinical characteristics and prognostic factors in intracranial hemorrhage patients with hematological diseases","volume":"101","author":"Zhang","year":"2022","journal-title":"Ann Hematol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/aje\/kwq332","article-title":"Odds ratios for mediation analysis for a dichotomous outcome","volume":"172","author":"Vanderweele","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"pkab069","DOI":"10.1093\/jncics\/pkab069","article-title":"Structural and functional brain imaging in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy: a systematic review","volume":"5","author":"Gandy","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1117096","DOI":"10.3389\/fonc.2023.1117096","article-title":"Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia","volume":"13","author":"Cheung","year":"2023","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/NCC.0000000000001164","article-title":"Cognitive function in adults with acute myeloid leukemia treated with chemotherapy: a systematic review","volume":"47","author":"Chan","year":"2024","journal-title":"Cancer Nurs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1016\/S2352-3026(16)30110-7","article-title":"Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis","volume":"3","author":"Cheung","year":"2016","journal-title":"Lancet Haematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12028-022-01603-2","article-title":"Cytotoxic edema and adverse clinical outcomes in patients with intracerebral hemorrhage","volume":"38","author":"Li","year":"2023","journal-title":"Neurocrit Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10143-025-03602-1","article-title":"Chemokines-like factor 1 as a serological biomarker in relation to disease severity and 90-day prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study","volume":"48","author":"Chen","year":"2025","journal-title":"Neurosurg Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.3390\/ijms26136195","article-title":"mCRP-Associated vascular pathophysiology in progression and outcome of intracerebral hemorrhage","volume":"26","author":"\u0218alari","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1664","DOI":"10.1212\/WNL.0000000000207065","article-title":"Changes in white matter microstructure over 3 years in people with and without stroke","volume":"100","author":"Egorova-Brumley","year":"2023","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1161\/STROKEAHA.121.037974","article-title":"Early deterioration, hematoma expansion, and outcomes in deep versus lobar intracerebral hemorrhage: the FAST trial","volume":"53","author":"Kuohn","year":"2022","journal-title":"Stroke"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/STROKEAHA.124.049008","article-title":"Volume tolerance and prognostic impact of hematoma expansion in deep and lobar intracerebral hemorrhage","volume":"56","author":"Morotti","year":"2025","journal-title":"Stroke"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e70318","DOI":"10.1111\/ene.70318","article-title":"Imaging and clinical prognostic features in lobar versus deep intracerebral hemorrhage in an unselected Swedish population","volume":"32","author":"Hillal","year":"2025","journal-title":"Eur J Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"101080","DOI":"10.1016\/j.lanepe.2024.101080","article-title":"Prevalence, predictors, and patterns of patient reported non-motor outcomes six months after stroke: a prospective cohort study","volume":"47","author":"Ozkan","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0261635","DOI":"10.1371\/journal.pone.0261635","article-title":"Understanding the interplay between lifestyle factors and emotional distress for hemorrhagic stroke survivors and their informal caregivers: protocol for a mixed methods dyadic natural history study","volume":"17","author":"Lester","year":"2022","journal-title":"PLoS One"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1928027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T05:36:02Z","timestamp":1788759362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1928027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":27,"alternative-id":["10.3389\/fmed.2026.1928027"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1928027","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1928027"}}